Tuberculosis in patientes treated with tumor necrosis factoralpha antagonists living in an endemic area. Is the risk worthwhile?
Tumor necrosis factor alpha antagonists (TNFA) are biological agents to treat chronicinflammatory and autoimmune diseases. However, their use is associated with an increasedrate of tuberculosis, endemic mycoses, and intracellular bacterial infections. Since tuberculosisis moderately to highly endemi...
Kaydedildi:
| Yayımlandı: | Biomédica |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Instituto Nacional de Salud
2007
|
| Konular: | |
| Online Erişim: | https://www.redalyc.org/articulo.oa?id=84327203 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|